Profound Medical

Yahoo Finance • 7 days ago

Profound Medical rises as TULSA procedure launched at Dallas Medical Center

[US Dollar Up Trend with Green Arrows] asbe * Shares of Profound Medical (NASDAQ:PROF [https://seekingalpha.com/symbol/PROF]) traded higher after the company announced that Dallas Medical Center is launching the TULSA procedure, a minim... Full story

Yahoo Finance • 7 days ago

Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment

TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company developing AI-powered, incision-free therapies for ablating diseased tissu... Full story

Yahoo Finance • last month

Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference

TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the abl... Full story

Yahoo Finance • 2 months ago

Profound Medical targets 70–75% revenue growth in 2025 as TULSA-AI and CAPTAIN trial progress fuel confidence

Earnings Call Insights: Profound Medical Corp. (PROF) Q2 2025 MANAGEMENT VIEW * CEO Arun Swarup Menawat summarized that "our sales team has been stabilized. That, combined with our large and growing TULSA-PRO pipeline, continues to dri... Full story

Yahoo Finance • 2 months ago

Profound Medical Posts Wider Loss in Q2

Key Points Revenue (GAAP) declined slightly year over year to $2.2 million in Q2 2025, missing GAAP revenue estimates by 32.3% on delayed capital sales. Operating expenses (GAAP) climbed approximately 65.8%, pushing net loss (GAAP) to $15... Full story

Yahoo Finance • 2 months ago

Plant Biotechnology Company Evaluation Report 2025 | Bayer, Syngenta, and BASF Lead with Advanced Crop Protection, Seeds, and Sustainable Farming Solutions

Dublin, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The "Plant Biotechnology - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering. The Plant Biotechnology Companies Quadrant is a comprehensive industry... Full story

Yahoo Finance • 2 months ago

Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow

TORONTO, July 24, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the abl... Full story

Yahoo Finance • 5 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF).  Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • 6 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF). Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 6 months ago

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that... Full story

Yahoo Finance • 2 years ago

Profound Medical Announces Proposed Public Offering of Common Shares

Profound Medical Corp. TORONTO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; NASDAQ:PROF) (“Profound” or the “Company”) is pleased to announce the commencement of an underwritten public offering in the United States... Full story

Yahoo Finance • 2 years ago

Profound Medical Announces CMS Extension of Temporary ‘Code’ for TULSA to ASC Setting

TORONTO, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the abl... Full story

Yahoo Finance • 2 years ago

Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference

TORONTO, May 18, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the abla... Full story

Yahoo Finance • 2 years ago

Profound Medical Annual and Special Meeting of Shareholders Voting Results

Profound Medical Corp. TORONTO, May 17, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX: PRN; NASDAQ: PROF) (“Profound” or the “Company”) is pleased to announce the voting results from its Annual and Special Meeting of Shareholders t... Full story

Yahoo Finance • 2 years ago

Profound Medical Announces First Quarter 2023 Financial Results

TORONTO, May 10, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the abla... Full story

Yahoo Finance • 2 years ago

Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow

Profound Medical Corp. TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-fre... Full story

Yahoo Finance • 2 years ago

Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Profound Medical Corp. TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-fre... Full story

Yahoo Finance • 3 years ago

Profound Medical Provides TULSA-PRO® Reimbursement Update

TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ab... Full story

Yahoo Finance • 3 years ago

Profound Medical Clarifies Recent Insider Buying

Profound Medical Inc. TORONTO, May 18, 2022 (GLOBE NEWSWIRE) -- In response to investor inquiries regarding insider trading activity, particularly with respect to recent open market stock purchases made by certain of its insiders, Profoun... Full story

Yahoo Finance • 3 years ago

Profound Medical Announces First Quarter 2022 Financial Results

Profound Medical Inc. TORONTO, May 09, 2022 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free t... Full story